Purdue Pharma /tags/purdue-pharma Purdue Pharma en-US Copyright Thu, 03 Mar 2022 18:43:18 GMT Purdue Pharma, Sacklers reach $6 billion deal with state attorneys general /npr-news/npr-news/2022-03-03/purdue-pharma-sacklers-reach-6-billion-deal-with-state-attorneys-general The deal, hashed out over weeks of intense negotiations, raises the amount paid by the Sacklers by more than $1 billion. In exchange, the family members win immunity from civil opioid lawsuits. Thu, 03 Mar 2022 18:43:18 GMT /npr-news/npr-news/2022-03-03/purdue-pharma-sacklers-reach-6-billion-deal-with-state-attorneys-general Brian Mann, Martha Bebinger Addiction Treatment During The COVID-19 Pandemic /show/all-sides-with-ann-fisher/2021-04-02/addiction-treatment-during-the-covid-19-pandemic Nearly half of all U.S. states want a share of a lawsuit settlement with Purdue Pharma to pay for programs to address record overdose deaths and a worsening opioid crisis during the pandemic. We take a look at the impact of the pandemic on addiction treatment and where the recovery community heads from here. Fri, 02 Apr 2021 09:00:35 GMT /show/all-sides-with-ann-fisher/2021-04-02/addiction-treatment-during-the-covid-19-pandemic Addiction Treatment During The COVID-19 Pandemic /show/all-sides-with-ann-fisher/2021-03-18/addiction-treatment-during-the-covid-19-pandemic OxyContin maker Purdue Pharma agreed on Monday to pay $4.28 billion to settle lawsuits alleging it helped to create the opioid epidemic.Nearly half of all… Thu, 18 Mar 2021 12:57:38 GMT /show/all-sides-with-ann-fisher/2021-03-18/addiction-treatment-during-the-covid-19-pandemic Federal Judge Approves Landmark $8.3 Billion Purdue Pharma Opioid Settlement /news-partners/2020-11-17/federal-judge-approves-landmark-8-3-billion-purdue-pharma-opioid-settlement The controversial deal hashed out between the Department of Justice and the maker of Oxycontin provides hundreds of millions of dollars of relief for communities hit hard by the opioid epidemic. Wed, 18 Nov 2020 02:27:18 GMT /news-partners/2020-11-17/federal-judge-approves-landmark-8-3-billion-purdue-pharma-opioid-settlement Brian Mann Sacklers Withdrew Nearly $11 Billion From Purdue As Opioid Crisis Mounted /2019-12-17/sacklers-withdrew-nearly-11-billion-from-purdue-as-opioid-crisis-mounted According to a court filing Monday, the family pulled about $10.7 billion from Purdue since 2008 — ramping up withdrawals even after executives pleaded guilty to misleading regulators about OxyContin. Tue, 17 Dec 2019 16:43:32 GMT /2019-12-17/sacklers-withdrew-nearly-11-billion-from-purdue-as-opioid-crisis-mounted Colin Dwyer Purdue Pharma, Accused Of Fueling Opioid Crisis, Files For Chapter 11 /news-partners/2019-09-16/purdue-pharma-accused-of-fueling-opioid-crisis-files-for-chapter-11 The bankruptcy follows the Sackler family, which owns Purdue, agreeing to surrender control of the company and offering $3 billion in cash to opioid-hit communities. Mon, 16 Sep 2019 06:01:00 GMT /news-partners/2019-09-16/purdue-pharma-accused-of-fueling-opioid-crisis-files-for-chapter-11 Bobby Allyn Purdue Pharma Reaches Tentative Deal To Settle Thousands Of Opioid Lawsuits /news-partners/2019-09-11/purdue-pharma-reaches-tentative-deal-to-settle-thousands-of-opioid-lawsuits The pending settlement likely means Purdue will avoid going to trial in the sprawling and complicated case involving some 2,300 local governments across 23 states. Thu, 12 Sep 2019 00:21:00 GMT /news-partners/2019-09-11/purdue-pharma-reaches-tentative-deal-to-settle-thousands-of-opioid-lawsuits Bobby Allyn, Brian Mann Plan Paused To Divide Potential Settlement From Opioid Lawsuits /news/2019-06-25/plan-paused-to-divide-potential-settlement-from-opioid-lawsuits State and local governments suing over the toll of a nationwide opioid crisis agree that companies in the drug industry should be held accountable, but… Tue, 25 Jun 2019 14:23:12 GMT /news/2019-06-25/plan-paused-to-divide-potential-settlement-from-opioid-lawsuits Geoff Mulvihill Opioid Litigation Brings Company Secrets Into The Public Eye /2019-03-13/opioid-litigation-brings-company-secrets-into-the-public-eye Lawsuits over the way drugmakers have marketed opioids are already putting a dent in companies' reputations. Litigation has forced the release of internal documents that are shifting the narrative. Wed, 13 Mar 2019 09:01:00 GMT /2019-03-13/opioid-litigation-brings-company-secrets-into-the-public-eye Brian Mann Drugmakers Seek Sanctions Over DeWine's '60 Minutes' Comments /news/2019-01-07/drugmakers-seek-sanctions-over-dewines-60-minutes-comments Several drug manufacturers targeted in lawsuits over the opioid epidemic have asked a federal judge in Cleveland to sanction Ohio's attorney general and… Mon, 07 Jan 2019 13:21:45 GMT /news/2019-01-07/drugmakers-seek-sanctions-over-dewines-60-minutes-comments Associated Press